Koninklijke Philips NV (PHG) Stock AnalysisPHGKoninklijke Philips NV

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others. It operates in the Healthcare sector.

Philips NV (PHG) is currently priced at $26.89, which is close to its 200-day simple moving average of $27.281. The RSI is high at 86.341, indicating that the stock may be overbought. While the forward P/E ratio is attractive at 12.7226, suggesting potential value, the stock has seen a significant insider selling trend with a 30126.47% increase in selling activity over the last quarter, which raises concerns about future performance. Therefore, it may be prudent to hold rather than buy at this time.

1 analysts cover PHG: 1 rate it Buy, 0 Hold and 0 Sell.